Rich Fama discussed with Marijuana Ventures the rise of CBD products and the lack of clarity at the federal level on regulating CBD. The manufacture and sale of CBD products remain legal gray areas, but companies are moving fast to establish their brands, jockeying for the advantage of being first-movers and capitalizing on the cannabidiol rush. Rich believes that we are, "going to see the FDA cracking down more significantly — products making health claims.”He also suggests avoiding any claims that a product could prevent, cure or diagnose a disease — including in pets, as those products are not immune from penalties related to false or deceptive claims, such as unsubstantiated medical benefits.

To read the full article, click here.